OICHARTS
8 AMThe 8 AM report →

INDGN

Indegene Limited · NSE · INE065X01017 · 272 sessions on record
₹593.50▲ +2.75 · +0.5%from ₹590.75 the session before · 1 Oct 2026 close · NSE end of day
Open
₹587.00
High
₹601.55
Low
₹580.00
Day's range
₹223.6% of the previous close
VWAP
₹589.98close +0.60% from it
Volume, shares
4.9 L0.90× the 20-session average
Turnover, ₹ crore
29
Trades
32,00015 shares per trade
Previous close
₹590.75+2.75 to the close
Price band, next session
₹534.15 – ₹652.8510% either side of the close · dynamic, widened in 5% steps when hit
Day range63% of the way up
₹580.00₹601.55
52-week range84% of the way up
₹414.00 23 Mar₹627.00 29 Sept

−5.3% from the high · +43% from the low

Futures and options

No derivatives listed on INDGN

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close
272 sessions on file · from 28 Aug
INDGN close and futures open interest over the last 126 sessions, with Nifty 50 rebased to the first close459.28565.92672.55axis spans 46%Nifty 50INDGN1 Apr6 Jul1 Oct126 sessions from 1 Apr to 1 Oct; the price axis spans 46 percent.

Quarterly results

consolidated · latest filed 30 Jul, 07:59 pm IST · NSE filings

Revenue ₹1,063 cr; profit ₹116 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of INDGN on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹Market on the day
Jun 2026filed 30 Jul₹1,063 cr—₹116 cr—4.81▲ +0.1%Nifty +0.3% · −0.2 pp
Mar 2026filed 29 Apr₹1,003 cr—₹80 cr—3.30▲ +0.9%Nifty −0.7% · +1.6 pp

Fundamentals

consolidated · filings to Jun 2026 · close ₹593.50 on 1 Oct

4.6 times book value, a 0.38% dividend yield, market cap ₹14,000 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹14,000 cron 1 Oct
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
4.6consolidated · balance sheet to Mar 2026
Book value a share
₹130.25consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity
0.00borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity
—needs two filed balance sheets
Dividend yield
0.38%₹2.25 a share in 365 days
Face value
₹2a share
Shares outstanding
24 cron 1 Oct
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
PeersBSE sub-group Healthcare Research, Analytics & Technology · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the BSE sub-group Healthcare Research, Analytics & Technology with market cap, price to earnings and price to book
StockMarket cap ₹P/EP/BClose ₹
SYNGENESyngene International Limited15,000 cron 1 Oct—3.0₹361.30
INDGNIndegene Limited14,000 cron 1 Oct—4.6₹593.50
SUVENSuven Life Sciences Limited8,700 cron 1 Oct—15₹308.30
VIMTALABSVimta Labs Limited2,600 cron 1 Oct—5.7₹584.35
TAKETAKE Limited190 cron 1 Oct—6.0₹12.65
BIBilcare Limited————

Shareholding

quarter to 30 Jun · pledge not stated · NSE filings

Foreign portfolio investors hold 9.9%, mutual funds 5.3%, insurance companies 0.0% and banks and financial institutions 3.4%, as filed for the quarter to 30 Jun.

By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of INDGN by category over the last 2 quarters with the change against the previous quarter
Category30 Jun31 Mar
Foreign portfolio investors9.92▼ −0.35 pp10.27
Mutual funds5.28▲ +0.58 pp4.70
Insurance companies0.02▲ +0.01 pp0.01
Banks and financial institutions3.44▼ −0.14 pp3.58
Individual investors17.56▼ −0.12 pp17.68
Bodies corporate5.95▲ +0.08 pp5.87
Other foreign holders33.61▼ −0.01 pp33.62
Others24.22▼ −0.05 pp24.27

Corporate actions

next results meeting 29 Oct · NSE and BSE records

Nothing upcoming on record; the board meets for results on 29 Oct 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of INDGN, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord dateSource
recent
31 Jul 2026dividend₹2.2531 Jul 2026NSE
13 Jun 2025dividend₹2.0013 Jun 2025NSE
29 Aug 2024otherAnnual General Meeting——NSE
Calendaras notified to the exchange
Next results
29 Oct 2026Financial Results/Other business matters To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Dividends in 365 days
₹2.25a share · ex-dates inside the year
Last dividend
₹2.25ex-date 31 Jul 2026

Price history

272 sessions on record · to 1 Oct · NSE end of day

INDGN is −1.1% over 20 sessions against Nifty's −6.2%, 5.3% below its 52-week high, realised volatility 22% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹INDGN %Nifty 50 %Difference pp
250 sessionssince 26 Sept₹575.38▲ +3.1%▼ −9.1%+12
120 sessionssince 9 Apr₹490.25▲ +21%▼ −5.7%+27
60 sessionssince 8 Jul₹493.72▲ +20%▼ −6.1%+26
20 sessionssince 2 Sept₹600.16▼ −1.1%▼ −6.2%+5.1
5 sessionssince 24 Sept₹594.09▼ −0.10%▼ −2.8%+2.7
1 sessionsince 30 Sept₹590.72▲ +0.47%▼ −0.88%+1.4
Averages of the closeclose against each average
5-session average
₹602.33close −1.5% from it
20-session average
₹593.05close +0.08% from it
50-session average
₹569.53close +4.2% from it
200-session average
₹516.01close +15% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹203.3% of the close
Average day's range, 20
₹183.0% of the close
Volume against 20 sessions
0.90×4.9 L vs 5.3 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
22%≈ ±1.4% a session · moved more than that on 6 of 20
Realised volatility, 60
27%≈ ±1.7% a session · moved more than that on 16 of 60
Realised volatility, 250
27%≈ ±1.7% a session · moved more than that on 63 of 250
Beta to Nifty, 60
1.24moved with Nifty on 41 of 60 sessions
Beta to Nifty, 250
0.80moved with Nifty on 146 of 250 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
9 up · 10 downof 19
Last 60 sessions
31 up · 28 downof 59
Last 250 sessions
118 up · 130 downof 248
Best session, 250
▲ +6.9%1 Apr
Worst session, 250
▼ −4.1%4 Feb

Indegene Limited is in 10 NSE indices

all 10 indices

0 bulletins on INDGN

The desk has not written about Indegene Limited yet. The tape carries every bulletin as it is published.

About Indegene Limited

exchange masters as of 18 Sept 2026 · classification by BSE
Company
Indegene Limited
Exchange
NSE · BSE 544172, group A
Listed on NSE
13 May 2024
Classification
Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology
Index
BSE 500
Face value
₹2 a share
ISIN
INE065X01017
Sessions on record
272
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
2 Oct, 02:28 am IST
Bulletins
0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.